Selected research
Industry Growth & Trends
Global Bradykinin B1 Receptor Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Bradykinin B1 Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Bradykinin B1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Bradykinin B1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bradykinin B1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Bradykinin B1 Receptor market include Grunenthal GmbH, Dompe Farmaceutici S.p.A., Boehringer Ingelheim GmbH and Axxam SpA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Bradykinin B1 Receptor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Bradykinin B1 Receptor market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bradykinin B1 Receptor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bradykinin B1 Receptor.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Bradykinin B1 Receptor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Bradykinin B1 Receptor Market by Company
Grunenthal GmbH
Dompe Farmaceutici S.p.A.
Boehringer Ingelheim GmbH
Axxam SpA
Bradykinin B1 Receptor Segment by Type
BI-113823
Others
Bradykinin B1 Receptor Segment by Application
Clinic
Hospital
Household
Bradykinin B1 Receptor Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bradykinin B1 Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bradykinin B1 Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bradykinin B1 Receptor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Bradykinin B1 Receptor companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- BI-113823
- Others
Applications
- Clinic
- Hospital
- Household
Companies covered
- Grunenthal GmbH
- Dompe Farmaceutici S.p.A.
- Boehringer Ingelheim GmbH
- Axxam SpA
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Bradykinin B1 Receptor Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Bradykinin B1 Receptor Market Size by Region (2021-2032)
- 1.4.1 Global Bradykinin B1 Receptor Market Size by Region (2021-2026)
- 1.4.2 Global Bradykinin B1 Receptor Market Size by Region (2027-2032)
- 1.5 Key Regions Bradykinin B1 Receptor Market Size (2021-2032)
- 1.5.1 North America Bradykinin B1 Receptor Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Bradykinin B1 Receptor Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Bradykinin B1 Receptor Market Size Growth Rate (2021-2032)
- 1.5.4 South America Bradykinin B1 Receptor Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Bradykinin B1 Receptor Market Size Growth Rate (2021-2032)
2 Bradykinin B1 Receptor Market by Type
- 2.1 Type Introduction
- 2.1.1 BI-113823
- 2.1.2 Others
- 2.2 Global Bradykinin B1 Receptor Market Size by Type
- 2.2.1 Global Bradykinin B1 Receptor Market Size Overview by Type (2021-2032)
- 2.2.2 Global Bradykinin B1 Receptor Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Bradykinin B1 Receptor Market Size Forecasted by Type (2027-2032)
- 2.3 Global Bradykinin B1 Receptor Market Size by Regions
- 2.3.1 North America Bradykinin B1 Receptor Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Bradykinin B1 Receptor Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Bradykinin B1 Receptor Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Bradykinin B1 Receptor Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Bradykinin B1 Receptor Market Size Breakdown by Type (2021-2026)
3 Bradykinin B1 Receptor Market by Application
- 3.1 Type Introduction
- 3.1.1 Clinic
- 3.1.2 Hospital
- 3.1.3 Household
- 3.2 Global Bradykinin B1 Receptor Market Size by Application
- 3.2.1 Global Bradykinin B1 Receptor Market Size Overview by Application (2021-2032)
- 3.2.2 Global Bradykinin B1 Receptor Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Bradykinin B1 Receptor Market Size Forecasted by Application (2027-2032)
- 3.3 Global Bradykinin B1 Receptor Market Size by Regions
- 3.3.1 North America Bradykinin B1 Receptor Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Bradykinin B1 Receptor Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Bradykinin B1 Receptor Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Bradykinin B1 Receptor Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Bradykinin B1 Receptor Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Bradykinin B1 Receptor Industry Trends
- 4.2 Bradykinin B1 Receptor Industry Drivers
- 4.3 Bradykinin B1 Receptor Industry Opportunities and Challenges
- 4.4 Bradykinin B1 Receptor Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Bradykinin B1 Receptor Revenue (2021-2026)
- 5.2 Global Bradykinin B1 Receptor Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Bradykinin B1 Receptor Key Company Headquarters & Area Served
- 5.4 Global Bradykinin B1 Receptor Company, Product Type & Application
- 5.5 Global Bradykinin B1 Receptor Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Bradykinin B1 Receptor Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Bradykinin B1 Receptor Players Market Share by Revenue in 2025
- 5.6.3 2025 Bradykinin B1 Receptor Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Grunenthal GmbH
- 6.1.1 Grunenthal GmbH Company Information
- 6.1.2 Grunenthal GmbH Business Overview
- 6.1.3 Grunenthal GmbH Bradykinin B1 Receptor Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Grunenthal GmbH Bradykinin B1 Receptor Product Portfolio
- 6.1.5 Grunenthal GmbH Recent Developments
- 6.2 Dompe Farmaceutici S.p.A.
- 6.2.1 Dompe Farmaceutici S.p.A. Company Information
- 6.2.2 Dompe Farmaceutici S.p.A. Business Overview
- 6.2.3 Dompe Farmaceutici S.p.A. Bradykinin B1 Receptor Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Dompe Farmaceutici S.p.A. Bradykinin B1 Receptor Product Portfolio
- 6.2.5 Dompe Farmaceutici S.p.A. Recent Developments
- 6.3 Boehringer Ingelheim GmbH
- 6.3.1 Boehringer Ingelheim GmbH Company Information
- 6.3.2 Boehringer Ingelheim GmbH Business Overview
- 6.3.3 Boehringer Ingelheim GmbH Bradykinin B1 Receptor Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Boehringer Ingelheim GmbH Bradykinin B1 Receptor Product Portfolio
- 6.3.5 Boehringer Ingelheim GmbH Recent Developments
- 6.4 Axxam SpA
- 6.4.1 Axxam SpA Company Information
- 6.4.2 Axxam SpA Business Overview
- 6.4.3 Axxam SpA Bradykinin B1 Receptor Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Axxam SpA Bradykinin B1 Receptor Product Portfolio
- 6.4.5 Axxam SpA Recent Developments
7 North America
- 7.1 North America Bradykinin B1 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Bradykinin B1 Receptor Market Size by Country (2021-2026)
- 7.3 North America Bradykinin B1 Receptor Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Bradykinin B1 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Bradykinin B1 Receptor Market Size by Country (2021-2026)
- 8.3 Europe Bradykinin B1 Receptor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Bradykinin B1 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Bradykinin B1 Receptor Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Bradykinin B1 Receptor Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Bradykinin B1 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Bradykinin B1 Receptor Market Size by Country (2021-2026)
- 10.3 South America Bradykinin B1 Receptor Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Bradykinin B1 Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Bradykinin B1 Receptor Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Bradykinin B1 Receptor Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst